PrEP acceptability and initiation among women engaged in sex work in Uganda: Implications for HIV prevention

被引:22
作者
Witte, Susan S. [1 ]
Filippone, Prema [1 ]
Ssewamala, Fred M. [2 ]
Nabunya, Proscovia [2 ]
Bahar, Ozge Sensoy [2 ]
Mayo-Wilson, Larissa Jennings [3 ]
Namuwonge, Flavia [2 ]
Damulira, Christopher [2 ]
Tozan, Yesim [4 ]
Kiyingi, Joshua [2 ]
Nabayinda, Josephine [2 ]
Mwebembezi, Abel [6 ]
Kagaayi, Joseph [5 ]
McKay, Mary [2 ]
机构
[1] Columbia Univ, Sch Social Work, 1255 Amsterdam Ave, New York, NY 10027 USA
[2] Washington Univ, Int Ctr Child Hlth & Dev ICHAD, Brown Sch, 1 Brookings Dr, St Louis, MO 63130 USA
[3] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth, 1025 E 7Th St, Bloomington, IN 47405 USA
[4] NYU, Sch Global Publ Hlth, 708 Broadway,4rd Floor, New York, NY 10003 USA
[5] Rakai Hlth Sci Program, POB 279, Kalisizo, Uganda
[6] Reach Youth, POB 24928, Kampala, Uganda
关键词
Sex work; FSW; Pre-exposure prophylaxis; PrEP; Stigma; FEMALE; STIGMA; SCALE;
D O I
10.1016/j.eclinm.2022.101278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Women engaged in sex work (WESW) are disproportionately affected by HIV. In Uganda, HIV prevalence among WESW is estimated at 37%, accounting for 18% of all new infections in the country. WESW experience poverty, gender-based violence, and other issues that reduce their power and limit their ability to negotiate condom use. Female-controlled strategies, including pre-exposure prophylaxis (PrEP), may afford women more transmission protection, but barriers to access and use persist. This cross-sectional study examined baseline PrEP acceptability and initiation among WESW recently enrolled in a randomized clinical trial in Uganda to test the impact of a combination HIV risk reduction and economic empowerment intervention on sexual risk outcomes (clinicaltrials.gov, NCT03583541). Methods A total of 542 WESW from 19 high HIV-prevalent geographical areas were enrolled in the Kyaterekera study between June 2019 and March 2020. Women were eligible for the study if they: (1) were age 18 or over; (2) reported engagement in transactional sex (a sex act in exchange for pay) in the past 30 days; and (3) reported engagement in one or more episodes of unprotected sex in the past 30 days. Women completed a baseline assessment, were tested for HIV and other sexually transmitted infections (STIs) at enrollment, and were connected with antiretroviral therapy (ART), STI treatment, or PrEP, based on need and interest. Descriptive statistics examined baseline data on PrEP acceptability and initiation. Independent variables (i.e. years in sex work, recent sexual coercion, perceived HIV and sex work stigmas, harmful alcohol use, barriers to medical care, and social support) were derived from the empirical literature and women's self-report. Bivariate analysis was performed to test associations between main effects of these variables. Using binomial logistic regression, predictive models were evaluated for two distinct outcomes-PrEP acceptability and PrEP initiation/uptake. Findings At baseline, 59% of women (n = 322) tested HIV negative. Among WESW testing negative, 11% (n = 36) were already PrEP enrolled. Most women reported willingness to use PrEP (n = 317; 91%). Slightly over half of WESW not already on PrEP agreed to initiate PrEP (n = 158; 55%). Logistic regression models demonstrate that acceptability of or willingness to use PrEP was significantly associated with fewer years engaged in sex work (AOR=.18, 95% CI 0.05-.66, p <.01) and greater perceived social support from family (AOR= 1.39, 95% CI 1.03-1.88, p <.05). PrEP initiation was negatively associated with greater perceived social support from friends (AOR=.81, 95% CI .68-0.97, p <.05) and positively associated with higher perceived stigma due to sex work among family members (AOR=2.20, 95% CI 1.15-4.22, p <.05). Interpretation Despite endorsing PrEP use, many WESW remain reluctant to use it. This gap in prevention practice highlights the heart of a failing PrEP prevention cascade. Findings point to the important role family and friend support may play in destigmatizing sex work and PrEP use for women. Social and structural-level efforts are needed to improve educational messaging and to integrate positive messaging into health promotion campaigns for women and their families, while also working toward decriminalizing sex work. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] PrEP initiation and adherence among Black cisgender women in Mississippi: The role of HIV and PrEP stigma and social support
    Knight, Deja
    Monger, Mauda
    Phillips, Karlye
    Antar, Amina
    Baral, Stefan
    Stockman, Jamila K.
    Nunn, Amy
    Chan, Philip
    Mayer, Kenneth
    Mena, Leandro
    Kershaw, Trace
    Willie, Tiara C.
    WOMENS HEALTH, 2024, 20
  • [2] HIV prevention in individuals engaged in sex work
    Busza, Joanna
    Matambanadzo, Primrose
    Phiri, Lawrence
    Meki, Bee
    Cowan, Frances M.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (01) : 1 - 8
  • [3] "I decided in my heart I have to complete the sessions ": A qualitative study on the acceptability of an evidence-based HIV risk reduction intervention among women engaged in sex work in Uganda
    Bahar, Ozge Sensoy
    Nabunya, Proscovia
    Nabayinda, Josephine
    Witte, Susan
    Kiyingi, Joshua
    Nsubuga, Edward
    Schriger, Simone
    Nattabi, Jennifer
    Mayo-Wilson, Larissa Jennings
    Nakigudde, Janet
    Tozan, Yesim
    Ssewamala, Fred M.
    PLOS ONE, 2023, 18 (01):
  • [4] Crossroads of choice: a qualitative study of the factors influencing decisions to transition from sex work among women engaged in sex work in Southern Uganda
    Nattabi, Jennifer
    Bahar, Ozge Sensoy
    Nabayinda, Josephine
    Nabunya, Proscovia
    Kiyingi, Joshua
    Kizito, Samuel
    Namuwonge, Flavia
    Nsubuga, Edward
    Witte, Susan S.
    Ssewamala, Fred M.
    BMC WOMENS HEALTH, 2025, 25 (01)
  • [5] Self-Reported Adherence to Antiretroviral Therapy (ART) Among Women Engaged in Commercial Sex Work in Southern Uganda
    Kiyingi, Joshua
    Nabunya, Proscovia
    Kizito, Samuel
    Nabayinda, Josephine
    Nsubuga, Edward
    Bahar, Ozge Sensoy
    Mayo-Wilson, Larissa Jennings
    Namuwonge, Flavia
    Nattabi, Jennifer
    Magorokosho, Natasja
    Tozan, Yesim
    Witte, Susan S.
    Ssewamala, Fred M.
    AIDS AND BEHAVIOR, 2023, 27 (03) : 1004 - 1012
  • [6] Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
    Kawuma, Rachel
    Ssemata, Andrew Sentoogo
    Bernays, Sarah
    Seeley, Janet
    SSM-POPULATION HEALTH, 2021, 13
  • [7] HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review
    de Carvalho, Nathalia Pacifico
    Pinto Mendicino, Cassia Cristina
    Fonseca Candido, Raissa Carolina
    Dutra Alecrim, Denyr Jeferson
    Menezes de Padua, Cristiane Aparecida
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (10): : 1234 - 1240
  • [8] Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence
    Moran, Alexander
    Mashele, Nyiko
    Mvududu, Rufaro
    Gorbach, Pamina
    Bekker, Linda-Gail
    Coates, Thomas J.
    Myer, Landon
    Joseph Davey, Dvora
    AIDS AND BEHAVIOR, 2022, 26 (01) : 205 - 217
  • [9] Perceived Risk of HIV Infection and Acceptability of PrEP among Men Who Have Sex with Men in Brazil
    Soares, Fabiane
    Magno, Laio
    da Silva, Luis Augusto, V
    Crosland Guimaraes, Mark Drew
    Leal, Andrea Fachel
    Knauth, Daniela
    Veras, Maria Amelia
    de Brito, Ana Maria
    Kendall, Carl
    Franco Sansigolo Kerr, Ligia Regina
    Dourado, Ines
    ARCHIVES OF SEXUAL BEHAVIOR, 2023, 52 (02) : 773 - 782
  • [10] Knowledge and Acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana
    Ogunbajo, Adedotun
    Leblanc, Natalie M.
    Kushwaha, Sameer
    Boakye, Francis
    Hanson, Samuel
    Smith, Martez D. R.
    Nelson, LaRon E.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (03): : 330 - 336